20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bone, cartilage, and soft tissue regeneration is a complex spatiotemporal process recruiting a variety of cell types, whose activity and interplay must be precisely mediated for effective healing post-injury. Although extensive strides have been made in the understanding of the immune microenvironment processes governing bone, cartilage, and soft tissue regeneration, effective clinical translation of these mechanisms remains a challenge. Regulation of the immune microenvironment is increasingly becoming a favorable target for bone, cartilage, and soft tissue regeneration; therefore, an in-depth understanding of the communication between immune cells and functional tissue cells would be valuable. Herein, we review the regulatory role of the immune microenvironment in the promotion and maintenance of stem cell states in the context of bone, cartilage, and soft tissue repair and regeneration. We discuss the roles of various immune cell subsets in bone, cartilage, and soft tissue repair and regeneration processes and introduce novel strategies, for example, biomaterial-targeting of immune cell activity, aimed at regulating healing. Understanding the mechanisms of the crosstalk between the immune microenvironment and regeneration pathways may shed light on new therapeutic opportunities for enhancing bone, cartilage, and soft tissue regeneration through regulation of the immune microenvironment.

          Related collections

          Most cited references298

          • Record: found
          • Abstract: found
          • Article: not found

          Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.

          The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom. Wnts are also key drivers of most types of tissue stem cells in adult mammals. Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer. Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease. Finally, we discuss strategies for Wnt-based therapies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Macrophages in Tissue Repair, Regeneration, and Fibrosis.

            Inflammatory monocytes and tissue-resident macrophages are key regulators of tissue repair, regeneration, and fibrosis. After tissue injury, monocytes and macrophages undergo marked phenotypic and functional changes to play critical roles during the initiation, maintenance, and resolution phases of tissue repair. Disturbances in macrophage function can lead to aberrant repair, such that uncontrolled production of inflammatory mediators and growth factors, deficient generation of anti-inflammatory macrophages, or failed communication between macrophages and epithelial cells, endothelial cells, fibroblasts, and stem or tissue progenitor cells all contribute to a state of persistent injury, and this could lead to the development of pathological fibrosis. In this review, we discuss the mechanisms that instruct macrophages to adopt pro-inflammatory, pro-wound-healing, pro-fibrotic, anti-inflammatory, anti-fibrotic, pro-resolving, and tissue-regenerating phenotypes after injury, and we highlight how some of these mechanisms and macrophage activation states could be exploited therapeutically.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response

              Tumor cells evade the immune surveillance by up-regulating surface expression of PD-L1, which interacts with PD-1 on T cells to elicit the immune checkpoint response 1,2 . Anti-PD-1 antibodies have shown remarkable promise in treating tumors, including metastatic melanoma 2–4 . However, patient response rate is low 4,5 . A better understanding of PD-L1-mediated immune evasion is needed to predict patient response and improve treatment efficacy. Here we report that metastatic melanoma releases a high level of extracellular vesicles (EVs), mostly in the form of exosomes, that carry PD-L1 on their surface. Interferon-γ (IFN-γ) up-regulates PD-L1 on these vesicles, which suppresses the function of CD8 T cells and facilitates tumor growth. In patients with metastatic melanoma, the level of circulating exosomal PD-L1 positively correlates with that of IFN-γ, and changes during the course of anti-PD-1 therapy. The magnitudes of the early on-treatment increase in circulating exosomal PD-L1, as an indicator of the adaptive response of the tumor cells to T cell re-invigoration, stratifies clinical responders from non-responders. Our study unveils a mechanism by which tumor cells systemically suppress the immune system, and provides a rationale for the application of exosomal PD-L1 as a predictor for anti-PD-1 therapy.
                Bookmark

                Author and article information

                Contributors
                xiongyuanmed@163.com
                mibobin@hust.edu.cn
                linze@hust.edu.cn
                huyiqiang@hust.edu.cn
                yul@ohio.edu
                zkknky@126.com
                adriana.panayi@icloud.com
                yutao247@tongji.edu.cn
                langchen199508@163.com
                liuzhenping@m.scnu.edu.cn
                apatel79@bwh.harvard.edu
                qianfeng@cqu.edu.cn
                szhou@bwh.harvard.edu
                liuguohui@hust.edu.cn
                Journal
                Mil Med Res
                Mil Med Res
                Military Medical Research
                BioMed Central (London )
                2095-7467
                2054-9369
                19 November 2022
                19 November 2022
                2022
                : 9
                : 65
                Affiliations
                [1 ]GRID grid.33199.31, ISNI 0000 0004 0368 7223, Department of Orthopedics, Union Hospital, Tongji Medical College, , Huazhong University of Science and Technology, ; Wuhan, 430022 China
                [2 ]GRID grid.33199.31, ISNI 0000 0004 0368 7223, Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, ; Wuhan, 430022 China
                [3 ]GRID grid.20627.31, ISNI 0000 0001 0668 7841, Department of Chemical and Biomolecular Engineering, , Ohio University, ; Athens, OH 45701 USA
                [4 ]GRID grid.190737.b, ISNI 0000 0001 0154 0904, Key Laboratory of Biorheological Science and Technology,Ministry of Education College of Bioengineering, , Chongqing University, ; Shapingba, Chongqing, 400044 China
                [5 ]GRID grid.38142.3c, ISNI 000000041936754X, Department of Plastic Surgery, Brigham and Women’s Hospital, , Harvard Medical School, ; Boston, MA 02152 USA
                [6 ]GRID grid.16821.3c, ISNI 0000 0004 0368 8293, Department of Orthopaedics, Ruijin Hospital, , Shanghai Jiao Tong University School of Medicine, ; Shanghai, 200025 China
                [7 ]GRID grid.9026.d, ISNI 0000 0001 2287 2617, Department of Physics, Center for Hybrid Nanostructure (CHyN), , University of Hamburg, ; Hamburg, 22761 Germany
                [8 ]GRID grid.263785.d, ISNI 0000 0004 0368 7397, Joint Laboratory of Optofluidic Technology and System,National Center for International Research on Green Optoelectronics, South China Academy of Advanced Optoelectronics, , South China Normal University, ; Guangzhou, 510006 China
                [9 ]GRID grid.38142.3c, ISNI 000000041936754X, Skeletal Biology Laboratory, Department of Orthopedic Surgery, Brigham and Women’s Hospital, , Harvard Medical School, ; Boston, MA 02120 USA
                [10 ]GRID grid.38142.3c, ISNI 000000041936754X, Harvard Stem Cell Institute, , Harvard University, ; Cambridge, MA 02138 USA
                Article
                426
                10.1186/s40779-022-00426-8
                9675067
                36401295
                26f9f046-31b0-45ea-952f-43f018421832
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 24 May 2022
                : 30 October 2022
                Categories
                Review
                Custom metadata
                © The Author(s) 2022

                immune microenvironment,regeneration,cell-cell interaction,tissue engineering,biomaterials

                Comments

                Comment on this article